[{"NetIncomeLoss_1_Q1_USD":-274000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":3411000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":16160000.0,"Liabilities_0_Q1_USD":30149000.0,"OperatingLeaseLiability_0_Q1_USD":3867000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q1_USD":18120000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":-7000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":1896000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q1_USD":3100000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":894000.0,"InventoryFinishedGoods_0_Q1_USD":1175000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":5006000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":35754000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1_Q1_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":9874000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":645000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":679000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":638000.0,"AssetsCurrent_0_Q1_USD":80863000.0,"PayablesToCustomers_0_Q1_USD":75000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-87000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":7023000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":3743000.0,"PaymentsToAcquireAvailableForSaleSecurities_1_Q1_USD":5820000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":6000.0,"AvailableForSaleSecurities_0_Q1_USD":18120000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":625000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":10800000.0,"IncomeTaxesPaidNet_1_Q1_USD":9000.0,"OtherAssetsNoncurrent_0_Q1_USD":4534000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-485000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":451000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":4466000.0,"InventoryRawMaterials_0_Q1_USD":4147000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":14919000.0,"EarningsPerShareBasic_1_Q1_USD":-0.02,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":18013000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":2527000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":13668000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-4236000.0,"AccountsReceivableNetCurrent_0_Q1_USD":8065000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":168000.0,"NumberOfReportableSegments_1_Q1_Segment":2.0,"CommonStockValue_0_Q1_USD":687000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":600000.0,"IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_1_Q1_USD":100000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":595000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1860000.0,"ContractWithCustomerAssetNet_0_Q1_USD":6566000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":27864000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-180000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":10882000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":5000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-790000.0,"AvailableForSaleSecuritiesCurrent_0_Q1_USD":18120000.0,"CostsAndExpenses_1_Q1_USD":22204000.0,"DeferredRevenueNoncurrent_0_Q1_USD":10073000.0,"IncreaseDecreaseInInventories_1_Q1_USD":236000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":1558000.0,"InvestmentIncomeNet_1_Q1_USD":41000.0,"CommonStockSharesIssued_0_Q1_shares":13739000.0,"Assets_0_Q1_USD":163556000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":1832000.0,"CommonStockSharesOutstanding_0_Q1_shares":13739000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.02,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":1759000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":1799000.0,"Goodwill_0_Q1_USD":27864000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-106000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":646000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1433000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":1832000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-4270000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":13668000.0,"InventoryWorkInProcess_0_Q1_USD":939000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":612000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":4969000.0,"LiabilitiesCurrent_0_Q1_USD":12446000.0,"AccountsPayableCurrent_0_Q1_USD":863000.0,"NonoperatingIncomeExpense_1_Q1_USD":-199000.0,"InterestExpense_1_Q1_USD":60000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":3553000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":155000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":4086000.0,"UndistributedEarningsOfForeignSubsidiaries_0_Q1_USD":0.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":12945000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.21,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":35754000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":1000000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":30346000.0,"DeferredRevenueCurrent_0_Q1_USD":4553000.0,"LeaseCost_1_Q1_USD":200000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":111554000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":726000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":2478000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.05,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":6000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":7004000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.05,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":599000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":651000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":357000.0,"CommonStockSharesAuthorized_0_Q1_shares":45000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":22297000.0,"OperatingIncomeLoss_1_Q1_USD":93000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":-165000.0,"InventoryNet_0_Q1_USD":6261000.0,"IncomeTaxesReceivable_0_Q1_USD":2544000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":5000.0,"PreferredStockValue_0_Q1_USD":null,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":310000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":163556000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2944000.0,"PreferredStockSharesAuthorized_0_Q1_shares":450000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":1433000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":456000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":1914000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":44000.0,"ProfitLoss_1_Q1_USD":-274000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":7630000.0,"StockholdersEquity_0_Q1_USD":133407000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1319000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":123000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-1370000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":304000.0,"Ticker":"SRDX","CIK":"924717","name":"SURMODICS INC","OfficialName":"Surmodics Inc. Common Stock","form":"10-Q","period":"20201231","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"609353600.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20210209"}]